Basal cell carcinoma (BCC) is the most common type of skin cancer, and it’s not even close. An estimated 3.6 million cases are diagnosed in the United States each year, accounting for roughly 8 out of every 10 non-melanoma skin cancers. Squamous cell carcinoma comes in a distant second, and melanoma, though far more dangerous, is considerably rarer than both.
Why BCC Is So Common
Basal cell carcinoma develops in the basal cells, which sit at the bottom of the outermost layer of your skin. These cells constantly divide to produce new skin cells, and that ongoing activity makes them vulnerable to DNA damage from ultraviolet radiation. When UV light damages a specific growth-control pathway in these cells, it essentially flips a switch that tells them to keep multiplying without the normal brakes. Ionizing radiation and chemical carcinogens can also trigger this process, but cumulative sun exposure is the primary driver for most people.
The damage builds over years and decades. That’s why BCC is most frequently diagnosed in adults over 50, though it’s increasingly appearing in younger people as well. The areas of skin that get the most sun, particularly the face, ears, neck, and scalp, are the most common sites.
What BCC Looks Like
BCC doesn’t always look the way people expect skin cancer to look. It takes several forms depending on the subtype, and some are easy to overlook or mistake for something harmless.
- Nodular BCC is the most common subtype. It typically appears as a pearly or waxy bump, often with visible tiny blood vessels on the surface. It can sometimes develop a central depression or ulcerate as it grows.
- Superficial BCC looks more like a flat, reddish, scaly patch. It can resemble eczema or psoriasis, which means people sometimes treat it with moisturizer for months before getting it checked. This subtype tends to appear on the trunk and shoulders rather than the face.
- Morpheaform BCC is the trickiest to spot. It appears as a flat, scar-like, pale or yellowish patch with poorly defined edges. This subtype tends to spread more extensively beneath the skin surface than it appears to on top, and it can invade surrounding nerves.
Both nodular and superficial BCC can be pigmented, meaning they contain brown or black coloring that can make them look like a mole or even melanoma. Any new growth, sore that won’t heal, or patch of skin that bleeds, crusts over, and then bleeds again is worth having examined.
Who Is Most at Risk
Your skin tone is one of the strongest predictors. People with very fair skin that burns easily and rarely tans (Fitzpatrick skin types 1 and 2) face the highest risk. Those with medium-toned skin that can tan but still burns are also at meaningful risk, since tanning itself is a sign of UV damage. People with deeply pigmented skin have more natural UV protection and develop BCC far less often, but it still occurs.
Other factors that raise your risk include a history of blistering sunburns (especially in childhood), chronic sun exposure over many years, use of indoor tanning beds, a weakened immune system, and prior radiation therapy to the skin. A family history of skin cancer also matters, as some people inherit a less efficient version of the growth-control pathway that normally keeps basal cells in check.
How Dangerous Is It?
Here’s the reassuring part: BCC is rarely life-threatening. It grows slowly and almost never spreads to distant parts of the body. The estimated rate of metastasis is somewhere between 0.0028% and 0.5% of all cases, making it an extraordinarily rare outcome.
That doesn’t mean BCC is harmless, though. Left untreated, it can grow deep into surrounding tissue, damaging muscle, bone, and nerves. A BCC near the eye, nose, or ear can cause significant disfigurement and functional problems if it’s allowed to expand for months or years. The morpheaform subtype is particularly concerning because its spread beneath the surface is often much wider than what’s visible.
For context, combined deaths from all non-melanoma skin cancers (BCC and squamous cell carcinoma together) account for roughly 1,200 deaths per year in the UK. Most of those deaths involve squamous cell carcinoma rather than BCC. The danger of BCC lies not in mortality but in local destruction of tissue when treatment is delayed.
How BCC Compares to Other Skin Cancers
Squamous cell carcinoma (SCC) is the second most common skin cancer. It develops in the flat cells closer to the skin’s surface and is more likely than BCC to spread to lymph nodes or other organs, though this is still uncommon with early treatment. SCC tends to appear as a firm red bump, a flat sore with a scaly crust, or a sore that heals and reopens.
Melanoma is far less common than either BCC or SCC but is responsible for the majority of skin cancer deaths. It develops in the pigment-producing cells and can metastasize aggressively if not caught early. Melanoma is the reason most skin cancer awareness campaigns focus on monitoring moles for changes in size, shape, and color.
Treatment and Cure Rates
BCC is one of the most treatable cancers. The specific approach depends on the size, location, and subtype, but the options all share high success rates.
Mohs surgery is considered the gold standard for BCC, especially on the face or in areas where preserving healthy tissue matters. The surgeon removes thin layers of skin one at a time, examining each layer under a microscope during the procedure, and stops as soon as no cancer cells remain. For new BCCs, this technique has a cure rate up to 99%. For cancers that have come back after prior treatment, the cure rate is around 95%.
Standard surgical excision, where the tumor is cut out along with a margin of surrounding healthy tissue, is effective for many BCCs and is often the simplest option for tumors on the body or limbs. Other approaches include curettage (scraping the tumor away), cryotherapy (freezing it), topical medications, and radiation therapy for patients who aren’t candidates for surgery.
The one catch is recurrence. Even after successful treatment, having one BCC significantly raises your odds of developing another. People who’ve had a BCC are typically advised to get regular skin checks and to be diligent about sun protection going forward.
Screening and Early Detection
No major U.S. professional organization currently recommends routine full-body skin exams for the general population. The U.S. Preventive Services Task Force has stated that the evidence is insufficient to determine whether universal screening by a clinician provides a net benefit for people without symptoms or risk factors.
That said, this applies to people with no personal or family history of skin cancer and no suspicious skin changes. If you have risk factors or notice anything new or changing on your skin, a clinical evaluation is appropriate regardless of screening guidelines. The American Academy of Dermatology also holds free public skin cancer screening events, which can be a useful entry point for people who haven’t had their skin examined before.
Self-examination remains practical and free. Checking your own skin every few months, particularly the areas that get the most sun, helps you notice new growths or changes early. Since BCC grows slowly, catching it within a few months of first appearance still typically means straightforward treatment with excellent outcomes.